First Subject Enrolled In The Tau NexGen Study For DIAD

Read about a Tau Nexgen Study of Eisai's Anti-mtbr Tau Antibody E2814 for Dominantly Inherited Alzheimer's Disease (DIAD)

Related Keywords

,University College London ,Eisai Co Ltd ,Alzheimer Network Trials Unit ,Washington University School Of Medicine ,Washington University School ,Tau Nexgen ,Dominantly Inherited Alzheimer ,University College ,Does This Mean ,Those Suffering From ,